Authors: Rieder, HL Arnadottir, T Trebucq, A Enarson, DA

Citation: Hl. Rieder et al., Tuberculosis treatment: dangerous regimens?, INT J TUBE, 5(1), 2001, pp. 1-3

Authors: Trebucq, A Anagonou, S Gninafon, M Lambregts, K Boulahbal, F

Citation: A. Trebucq et al., Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy, INT J TUBE, 3(6), 1999, pp. 466-470

Authors: Trebucq, A Rieder, HL

Citation: A. Trebucq et Hl. Rieder, Two excellent management tools for national tuberculosis programmes - Reply, INT J TUBE, 3(5), 1999, pp. 455-455

Authors: Trebucq, A Caudron, JM Pinel, J

Citation: A. Trebucq et al., Requirements for anti-tuberculosis drug tender requests, INT J TUBE, 3(11), 1999, pp. S358-S361

Authors: Iseman, MD Spinaci, S Weil, D Coulibaly, IM Cruz, R Mantala, J Roscigno, G",Bakhle,"Trebucq, A Ellard, G Mitchison, DA Fourie, PB de Goege, M Frieden, T Ottmani, S

Citation: Md. Iseman et al., Panel discussion III, INT J TUBE, 3(11), 1999, pp. S381-S387

Authors: Trebucq, A

Citation: A. Trebucq, Tuberculosis in prisons, LANCET, 353(9171), 1999, pp. 2244-2244